The latest price target for Ocugen (NASDAQ:OCGN) was reported by Chardan Capital on November 18, 2024. The analyst firm set a price target for $6.00 expecting OCGN to rise to within 12 months (a possible 679.12% upside). 12 analyst firms have reported ratings in the last year.

The latest analyst rating for Ocugen (NASDAQ:OCGN) was provided by Chardan Capital, and Ocugen maintained their buy rating.

The last upgrade for Ocugen Inc happened on March 1, 2023 when Chardan Capital raised their price target to $3.5. Chardan Capital previously had a neutral for Ocugen Inc.

There is no last downgrade for Ocugen.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocugen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocugen was filed on November 18, 2024 so you should expect the next rating to be made available sometime around November 18, 2025.

While ratings are subjective and will change, the latest Ocugen (OCGN) rating was a maintained with a price target of $6.00 to $6.00. The current price Ocugen (OCGN) is trading at is $0.77, which is out of the analyst’s predicted range.